SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 119 filers reported holding SUTRO BIOPHARMA INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $195,000 | +6.0% | 35,119 | -0.7% | 0.00% | – |
Q2 2022 | $184,000 | -13.2% | 35,375 | +0.1% | 0.00% | – |
Q1 2022 | $212,000 | -91.8% | 35,335 | -79.7% | 0.00% | -100.0% |
Q4 2021 | $2,588,000 | -0.0% | 173,957 | +26.9% | 0.00% | -33.3% |
Q3 2021 | $2,589,000 | +0.7% | 137,081 | -0.9% | 0.00% | +50.0% |
Q2 2021 | $2,571,000 | -22.8% | 138,314 | -5.4% | 0.00% | -33.3% |
Q1 2021 | $3,330,000 | +4.9% | 146,274 | +0.1% | 0.00% | -25.0% |
Q4 2020 | $3,173,000 | +123.3% | 146,146 | +3.4% | 0.00% | +100.0% |
Q3 2020 | $1,421,000 | +13.7% | 141,369 | -12.3% | 0.00% | 0.0% |
Q2 2020 | $1,250,000 | +3.3% | 161,105 | +35.8% | 0.00% | +100.0% |
Q1 2020 | $1,210,000 | +2925.0% | 118,644 | +3140.8% | 0.00% | – |
Q4 2019 | $40,000 | -18.4% | 3,661 | -32.7% | 0.00% | – |
Q3 2019 | $49,000 | +16.7% | 5,436 | +48.5% | 0.00% | – |
Q2 2019 | $42,000 | -38.2% | 3,661 | -39.0% | 0.00% | – |
Q1 2019 | $68,000 | +25.9% | 6,000 | 0.0% | 0.00% | – |
Q4 2018 | $54,000 | -40.0% | 6,000 | 0.0% | 0.00% | – |
Q3 2018 | $90,000 | – | 6,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SV Health Investors, LLC | 1,824,542 | $39,611,000 | 19.08% |
Samsara BioCapital, LLC | 1,675,579 | $36,377,000 | 3.66% |
SILVERARC CAPITAL MANAGEMENT, LLC | 185,000 | $4,016,000 | 2.33% |
Affinity Asset Advisors, LLC | 200,000 | $4,342,000 | 2.30% |
Altium Capital Management LP | 276,719 | $6,008,000 | 2.24% |
FRAZIER MANAGEMENT LLC | 1,001,421 | $21,741,000 | 1.67% |
BVF INC/IL | 1,854,162 | $40,254,000 | 1.58% |
Asymmetry Capital Management, L.P. | 157,583 | $3,421,000 | 1.56% |
Parkman Healthcare Partners LLC | 266,645 | $5,789,000 | 1.48% |
AJU IB Investment Co., Ltd. | 175,000 | $3,799,000 | 1.44% |